Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Neuroscience
Reference39 articles.
1. Pascuzzi RM: Blinded and seeing the light, (John Noseworthy), Lou Gehrig and other tales of enlightenment. Semin Neurol 1998, 18:415–418.
2. Rowland LP, Shneider NA: Amyotrophic lateral sclerosis. N Engl J Med 2001, 344:1688–1700.
3. Young FE, Norris JA, Levitt JA, Nightingale SL: The FDA’s new procedures for the use of investigational drugs in treatment. JAMA 1988, 25:2267–2270.
4. Cedarbaum JM, Stambler N: Disease status and use of ventilatory support by ALS patients. BDNF Study Group. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2:19–22.
5. Miller RG, Mitchell JD, Lyon M, Moore DH: Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Neuromuscular Disease Group. Cochrane Database of Systematic Reviews 2004, 2. This work uses a meta-analysis to analyze the data of three reported randomized trials of a total of 876 patients examining the efficacy of riluzole in ALS. The results indicate that riluzole treatment extends survival by about 2 months.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献